Reset filters
  • 30 October 2017

Curing hepatitis C with DAAs linked to 71% reduction in liver cancer

Read the article
George Iaonnou presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com
  • 27 October 2017

Hepatitis C halved in Spanish people living with HIV in one year due to treatment

Read the article
Juan Berenguer and Juan González from GeSIDA at EACS 2017. Image credit: @GeSIDA
  • 26 October 2017

New EACS treatment guidelines

Read the article
New EACS treatment guidelines
  • 24 October 2017

Maviret cures most people with HCV genotype 3 and those with cirrhosis

Read the article
Steven Flamm presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com
  • 23 October 2017

Hepatitis C cure leads to improved quality of life

Read the article
Zobair Younossi presenting at The Liver Meeting 2017. Photo by Liz Highleyman, hivandhepatitis.com
  • 17 October 2017

Restrictions on free DAA access in many European countries contrary to guidelines and undermine HCV elimination targets, say researchers

Read the article
  • 15 September 2017

High prices of DAAs mean there's been little progress towards achieving WHO target of eliminating HCV by 2030

Read the article
  • 30 August 2017

The availability of direct-acting antivirals is reducing disparities in the uptake of hepatitis C treatment

Read the article
  • 10 August 2017

Treatment with DAAs reduces the risk of mortality in the first 18 months after the completion of treatment

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.